Safety and efficacy of vigabatrin and carbamazepine. CPMP. The Committee for Proprietary Medicinal Products
Elferink, A.J.; Toivonen, M.; van Bronswijk, H.
Lancet 354(9187): 1387-1388
1999
ISSN/ISBN: 0140-6736 PMID: 10533890 Document Number: 499773
Document emailed within 1 workday
Related Documents
Ruys-Dudok van Heel, I.; Cohen, A.F.; Wit, J.M.; van der Heijden, A.J.; van den Anker, J.N.; van Meurs, A.H. 1998: Clinical drug research in children: current international guidelines. Committee for Proprietary Medicinal Products Nederlands Tijdschrift Voor Geneeskunde 142(1): 6-9Celis, P.; Silvester, G. 2004: European Regulatory guidance on virus safety of recombinant proteins, monoclonal antibodies and plasma derived medicinal products Developments in Biologicals 118: 3-10
Placidi, G.F.; Lenzi, A.; Lazzerini, F.; Cassano, G.B.; Akiskal, H.S. 1986: The comparative efficacy and safety of carbamazepine versus lithium: a randomized, double-blind 3-year trial in 83 patients Journal of Clinical Psychiatry 47(10): 490-494
Ketter, T.A.; Post, R.M.; Parekh, P.I.; Worthington, K. 1995: Addition of monoamine oxidase inhibitors to carbamazepine: preliminary evidence of safety and antidepressant efficacy in treatment-resistant depression Journal of Clinical Psychiatry 56(10): 471-475
Kusum, M.; Klinbuayaem, V.; Bunjob, M.; Sangkitporn, S. 2004: Preliminary efficacy and safety of oral suspension SH, combination of five chinese medicinal herbs, in people living with HIV/AIDS ; the phase I/II study Journal of the Medical Association of Thailand 87(9): 1065-1070
D'Arcy, P.F. 1999: Reactions and interactions of drugs. Safety measures from Drug Safety Committee of the United Kingdom Journal de Pharmacie de Belgique 54(2): 44-47
Kes, P.; Mesar, I.; Bašić-Jukić, N.; Rački, S. 2014: What doctors need to know about biosimilar medicinal products? Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 68(2): 201-205
Ernst, E. 2004: Risks of herbal medicinal products Pharmacoepidemiology and Drug Safety 13(11): 767-771
Ruebsaamen, M. 1995: Liability for HIV infection by blood and blood products: A summary of the most important results of the final report of the 3rd fact-finding committee HIV infections by blood and blood products of the 12th German Bundestag AIDS-Forschung 10(6): 305-318
Kaye, S.; Ortiz, T.; Miranda Massari, J.R.; González, M.J. 2003: Adverse effects and interactions of medicinal herbal products Boletin de la Asociacion Medica de Puerto Rico 95(6): 32-36; 40-41
Marimbert, J. 2005: Sanitary risk: medicinal products and medical devices La Revue du Praticien 55(18): 2026-2032
Rüsing, D.; Bauer, K.; Verspohl, E.J. 2004: Drug and medicinal products for the consumer. a critical evaluation Medizinische Monatsschrift für Pharmazeuten 27(3): 84-91
Bass, R.; Ulbrich, B.; Hildebrandt, A.G.; Weissinger, J.; Doi, O.; Baeder, C.; Fumero, S.; Harada, Y.; Lehmann, H.; Manson, J. 1991: Draft guideline on detection of toxicity to reproduction for medicinal products Adverse Drug Reactions and Toxicological Reviews 10(3): 127-141
Wiatrzyk, A.; Polak, M.; Czajka, U.; Krysztopa-Grzybowska, K.; Lutyńska, A. 2013: Phenotypic and genotypic characterization of probiotic bacterial strains used in medicinal products Medycyna Doswiadczalna i Mikrobiologia 65(1): 47-56
Kalny, P.; Wyderska, S.; Fijałek, Z.; Wroczyński, P. 2012: Determination of selected elements in different pharmaceutical forms of some Polish herbal medicinal products Acta Poloniae Pharmaceutica 69(2): 279-283
Zmudzki, J. 2003: Risk analysis rules for the establishing of maximum residue limits of veterinary medicinal products Roczniki Panstwowego Zakladu Higieny 54 Suppl: 12-13
Vos, E.J.; Huitema, A.D.R. 2006: Defining trials of medicinal products according to the revised Dutch Medical Research in Human Subjects Act (WMO) Nederlands Tijdschrift Voor Geneeskunde 150(38): 2104-2107
Denicoff, K.D.; Smith-Jackson, E.E.; Disney, E.R.; Ali, S.O.; Leverich, G.S.; Post, R.M. 1997: Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder Journal of Clinical Psychiatry 58(11): 470-478
Sato, T.; Kariya, K. 1996: Theoretical prediction of safety and efficacy of drugs--safety Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 108(3): 183-185
McQuade, J. 1976: The use and abuse of a safety committee Dimensions in Health Service 53(2): 14-5 17